Hundreds of Institutional Investors to Attend Conference
LAS VEGAS, Sept. 10 /PRNewswire-FirstCall/ -- Skinvisible, Inc. (OTC Bulletin Board: SKVI / Website: http://www.skinvisible.com), the developers of Invisicare(R), a proprietary polymer delivery system for topically applied dermatology products, today announced that Mr. Terry Howlett, President & CEO, will present at the 4th annual Merriman Curhan Ford & Co. Investor Summit on September 18, 2007 at 2:15 PM. This event will be held at the Mark Hopkins InterContinental Hotel in San Francisco.
More information about the conference can be found at: http://www.merrimanco.com
About Merriman Curhan Ford & Co.
Merriman Curhan Ford & Co., a subsidiary of MCF Corporation (Amex: MEM), is an investment bank and securities broker-dealer focused on fast-growing companies and growth-oriented institutional investors. It provides investment research, brokerage and trading services primarily to institutions, as well as advisory and investment banking services to corporate clients. Its mission is to become a leader in the researching, advising, financing and trading of fast-growing companies. Merriman Curhan Ford & Co. is registered with the Securities and Exchange Commission as a broker-dealer and is a member of the National Association of Securities Dealers, Inc. and SIPC.
About Skinvisible Pharmaceuticals, Inc.
Skinvisible Pharmaceuticals, a wholly owned subsidiary of Skinvisible
Inc., is a research-and-development company whose primary business
objective is to
|SOURCE Skinvisible, Inc.|
Copyright©2007 PR Newswire.
All rights reserved